Ticker > Company >

Zydus Wellness share price

Zydus Wellness Ltd.

NSE: ZYDUSWELL BSE: 531335 SECTOR: Consumer Food  2.26 L   1.34 K   190

2540.05
+57.75 (2.33%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 2562.75

Today's Low

₹ 2440

52 Week High

₹ 2515

52 Week Low

₹ 1493

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16162.88 Cr.

Enterprise Value

16289.48 Cr.

No. of Shares

6.36 Cr.

P/E

514.74

P/B

4

Face Value

₹ 10

Div. Yield

0.24 %

Book Value (TTM)

₹  635.16

CASH

2.4 Cr.

DEBT

129 Cr.

Promoter Holding

69.63 %

EPS (TTM)

₹  4.93

Sales Growth

19.53%

ROE

0.76 %

ROCE

1.1%

Profit Growth

-9.2 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Zydus Wellness Ltd.

Naturell Max Protein Ritebite Complan Glucon-D nycil everyuth Sugar Free Nutralite SugarLite

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year19.53%
3 Year10.6%
5 Year13.73%

Profit Growth

1 Year-9.2%
3 Year34.06%
5 Year22.44%

ROE%

1 Year0.76%
3 Year1.08%
5 Year-0.29%

ROCE %

1 Year1.1%
3 Year1.15%
5 Year0.21%

Debt/Equity

0.032

Price to Cash Flow

353.67

Interest Cover Ratio

10.0444

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 69.63 0.00
Mar 2025 69.63 0.00
Dec 2024 69.62 0.00
Sep 2024 69.62 0.00
Jun 2024 69.62 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 34.0620641229026% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 10.0444.
  • The company has an efficient Cash Conversion Cycle of -10.4069 days.
  • The company has a high promoter holding of 69.63%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 11.8614212962848.

 Limitations

  • The company has shown a poor revenue growth of 10.6043728329348% for the Past 3 years.
  • Company has a poor ROE of 1.08213333333333% over the past 3 years.
  • Company has a poor ROCE of 1.15293333333333% over the past 3 years
  • The company has a low EBITDA margin of -0.29752% over the past 5 years.
  • The company is trading at a high PE of 514.74.
  • The company is trading at a high EV/EBITDA of 314.4688.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 63.4 63.3 88.4 77.5 87.7
Total Expenditure 58.1 55.8 73.5 68.6 75.2
Operating Profit 5.3 7.5 14.9 8.9 12.5
Other Income 4.8 4.1 3.1 0.3 0.5
Interest 0.8 0.2 1.4 2.1 2.3
Depreciation 0.9 0.9 1 0.9 1.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.4 10.5 15.6 6.2 9.5
Tax 2.2 2.5 3.9 1.5 2.5
Profit After Tax 6.2 8 11.7 4.7 7
Adjusted EPS (Rs) 0.97 1.26 1.84 0.74 1.1

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 113.83 216.25 251.2 244.8 292.6
Total Expenditure 163.55 221.57 213.2 212 256.4
Operating Profit -49.72 -5.32 38 32.8 36.2
Other Income 66.8 15.4 13.8 18.2 12.7
Interest 74.66 2.02 1.1 2.6 4.5
Depreciation 3.49 2.84 3.5 3.6 3.7
Exceptional Items -127.06 0 0 0 0
Profit Before Tax -188.13 5.22 47.2 44.8 40.7
Tax -5.99 -7.48 -19.2 11.1 10.1
Net Profit -182.14 12.7 66.4 33.7 30.6
Adjusted EPS (Rs.) -28.62 2 10.44 5.3 4.81

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 63.63 63.63 63.6 63.6 63.6
Total Reserves 3955.66 3936.55 3970.7 3972.3 3971
Borrowings 0 0 0 0 44
Other N/C liabilities -12.88 -21.08 -39.3 -28 -16.9
Current liabilities 93.55 87.43 28.5 75 129
Total Liabilities 4099.96 4066.53 4023.5 4082.9 4190.7
Assets
Net Block 44.05 45 54.5 54.1 57
Capital WIP 0.87 1.77 0.5 4 8
Intangible WIP 0 0 0 0 0
Investments 3671.25 3671.25 3671.3 3671.3 4061
Loans & Advances 251.55 226.73 127.2 221.7 7.2
Other N/C Assets 0 0 0 0 0
Current Assets 132.24 121.78 170 131.8 57.5
Total Assets 4099.96 4066.53 4023.5 4082.9 4190.7
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations -188.13 5.22 47.2 44.8 40.7
Adjustment 138.97 -11.25 -8.1 -11.8 -2.4
Changes in Assets & Liabilities -5.01 -7.51 -2.2 -6.7 5.4
Tax Paid 2.44 -2.73 -0.2 -0.3 2
Operating Cash Flow -51.73 -16.27 36.7 26 45.7
Investing Cash Flow 816.14 27.31 0.7 -47.1 -96.3
Financing Cash Flow -710.21 -37.69 -79.3 15.4 43.4
Net Cash Flow 54.2 -26.65 -41.9 -5.7 -7.2

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 69.62 69.62 69.62 69.63 69.63
jasodaben babubhai patel - - - 0.01 0.01
zydus family trust(truste... 12.01 12.01 12.01 12.01 12.01
zydus lifesciences limite... 57.59 57.59 57.59 57.59 57.59
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 30.38 30.38 30.38 30.37 30.37
investor education and pr... - - 0.16 - 0.16
llp 0.02 0.01 0.01 0.01 0.03
nippon life india trustee... 3.97 4.18 5.36 6.10 6.16
parag parikh flexi cap fu... - - - - 7.27
quant mutual fund - quant... - 3.87 3.87 3.86 4.44
icici prudential value di... 1.63 1.43 1.24 1.21 -
investor education and pr... 0.16 0.16 - 0.16 -
threpsi care llp 10.12 7.45 7.27 7.27 -
sbi small cap fund 2.21 1.99 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CARE RATINGS
Credit CRISIL
Credit CARE
TYPE AGENCY Link
TYPE AGENCY Link
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research BOB Capital Market
Research HDFC Securities
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research BOB Capital Market
Research BOB Capital Market
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research Edelweiss
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q3FY24
Concall Q3FY22
Concall Q2FY22
Concall Q1FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY24
Presentation Q3FY22
Presentation Q1FY25
Presentation Q1FY23
Presentation Q1FY21
Presentation Q1FY20

Company News

Zydus Wellness Stock Price Analysis and Quick Research Report. Is Zydus Wellness an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Zydus Wellness. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zydus Wellness has a PE ratio of 517.144246747457 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zydus Wellness has ROA of 0.7397% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zydus Wellness has a Current ratio of 0.4457.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zydus Wellness has a ROE of 0.7583%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Zydus Wellness has a Debt to Equity ratio of 0.032 which means that the company has low proportion of debt in its capital.

  • Sales growth: Zydus Wellness has reported revenue growth of 19.5261% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Zydus Wellness for the current financial year is 12.3718386876282%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zydus Wellness is Rs 6 and the yield is 0.2353%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Zydus Wellness is Rs 4.9346. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Zydus Wellness in Ticker for free. Also, one can get the intrinsic value of Zydus Wellness by using Valuation Calculators, which are available with a Finology ONE subscription. 

Zydus Wellness FAQs

Q1. What is Zydus Wellness share price today?
Ans: The current share price of Zydus Wellness is Rs 2551.9.

Q2. What is the market capitalisation of Zydus Wellness?
Ans: Zydus Wellness has a market capitalisation of Rs 16238.28682736 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Zydus Wellness?
Ans: The PE ratio of Zydus Wellness is 517.144246747457 and the P/B ratio of Zydus Wellness is 4.01775501660459, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Zydus Wellness share?
Ans: The 52-week high share price of Zydus Wellness is Rs 2517, and the 52-week low share price of Zydus Wellness is Rs 1493.2.

Q5. Does Zydus Wellness pay dividends?
Ans: Currently, Zydus Wellness pays dividends. Dividend yield of Zydus Wellness is around 0.2353%.

Q6. What are the face value and book value of Zydus Wellness shares?
Ans: The face value of Zydus Wellness shares is Rs 10, while the book value per share of Zydus Wellness is around Rs 635.1557. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Zydus Wellness?
Ans: Zydus Wellness has a total debt of Rs 129 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Zydus Wellness?
Ans: The ROE of Zydus Wellness is 0.7583% and ROCE of Zydus Wellness is 1.0958%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Zydus Wellness a good buy for the long term?
Ans: The Zydus Wellness long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Zydus Wellness undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Zydus Wellness appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Zydus Wellness’s financials?
Ans: You can review Zydus Wellness’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Zydus Wellness
X